Works matching IS 03407004 AND DT 2015 AND VI 64 AND IP 6
Results: 14
CEA/CD3-bispecific T cell-engaging (BiTE) antibody-mediated T lymphocyte cytotoxicity maximized by inhibition of both PD1 and PD-L1.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 6, p. 677, doi. 10.1007/s00262-015-1671-y
- By:
- Publication type:
- Article
Intravesical chitosan/interleukin-12 immunotherapy induces tumor-specific systemic immunity against murine bladder cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 6, p. 689, doi. 10.1007/s00262-015-1672-x
- By:
- Publication type:
- Article
Wilms tumor 1 peptide vaccination combined with temozolomide against newly diagnosed glioblastoma: safety and impact on immunological response.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 6, p. 707, doi. 10.1007/s00262-015-1674-8
- By:
- Publication type:
- Article
CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 6, p. 697, doi. 10.1007/s00262-015-1675-7
- By:
- Publication type:
- Article
FoxP3 and IL-17 cells are correlated with improved prognosis in cervical adenocarcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 6, p. 745, doi. 10.1007/s00262-015-1678-4
- By:
- Publication type:
- Article
Gene-mediated cytotoxic immunotherapy as adjuvant to surgery or chemoradiation for pancreatic adenocarcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 6, p. 727, doi. 10.1007/s00262-015-1679-3
- By:
- Publication type:
- Article
Augmentation of autologous T cell reactivity with acute myeloid leukemia (AML) blasts by Toll-like receptor (TLR) agonists.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 6, p. 737, doi. 10.1007/s00262-015-1680-x
- By:
- Publication type:
- Article
Overexpression of apolipoprotein A-I fused to an anti-transforming growth factor beta peptide modulates the tumorigenicity and immunogenicity of mouse colon cancer cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 6, p. 717, doi. 10.1007/s00262-015-1681-9
- By:
- Publication type:
- Article
Evaluation of serum osteopontin level and gene polymorphism as biomarkers: analyses from the Nordic Adjuvant Interferon alpha Melanoma trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 6, p. 769, doi. 10.1007/s00262-015-1686-4
- By:
- Publication type:
- Article
Impairment of lymphocyte function following yttrium-90 DOTATOC therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 6, p. 755, doi. 10.1007/s00262-015-1687-3
- By:
- Publication type:
- Article
Anti-programmed cell death-1 therapy and insulin-dependent diabetes: a case report.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 6, p. 765, doi. 10.1007/s00262-015-1689-1
- By:
- Publication type:
- Article
Growth arrest and DNA damage-inducible protein (GADD34) enhanced liver inflammation and tumorigenesis in a diethylnitrosamine (DEN)-treated murine model.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 6, p. 777, doi. 10.1007/s00262-015-1690-8
- By:
- Publication type:
- Article
Targeted treatment of metastatic castration-resistant prostate cancer with sipuleucel-T immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 6, p. 655, doi. 10.1007/s00262-015-1707-3
- By:
- Publication type:
- Article
Preclinical activity of anti-CCR7 immunotherapy in patients with high-risk chronic lymphocytic leukemia.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 6, p. 665, doi. 10.1007/s00262-015-1670-z
- By:
- Publication type:
- Article